西安交通大学学报（医学版）2024，Vol.45Issue(1)：15-22,8.DOI:10.7652/jdyxb202401003
核医学诊疗一体化在分化型甲状腺癌术后评估中的应用
Nuclear medicine theranostics for the management of differentiated thyroid carcinoma
摘要
Abstract
With the increase of its incidence,differentiated thyroid carcinoma(DTC)has become a global concern.Over the recent decades,the guidelines for the management of DTC have been kept updating along with the development of nuclear medicine theranostics and molecular biology.The present article will systematically expound on the 131I pre-treatment evaluation system based on the clinical practice of nuclear medicine theranostics,the latest evidence-based medical evidence,and guideline recommendations.关键词
甲状腺肿瘤/核医学/诊疗一体化Key words
thyroid neoplasm/nuclear medicine/theranostics分类
医药卫生引用本文复制引用
张英杰,林岩松..核医学诊疗一体化在分化型甲状腺癌术后评估中的应用[J].西安交通大学学报（医学版）,2024,45(1):15-22,8.基金项目
国家重点研发计划"政府间国际科技创新合作/港澳台科技创新合作"重点专项(No.2019YFE0106400) （No.2019YFE0106400）
中央高水平医院临床科研业务费资助(No.2022-PUMCH-B-072) （No.2022-PUMCH-B-072）
国家自然科学基金项目(No.81771875) （No.81771875）
山东省自然科学基金项目(No.ZR2019PH051)Supported by Project on Inter-Governmental International Scientific and Technological Innovation Cooperation in National Key Projects of Research and Development Plan(No.2019YFE0106400),National High Level Hospital Clinical Research Funding(No.2022-PUMCH-B-072),the National Natural Science Foundation of China(No.81771875)and Shandong Provincial Natural Science Founda-tion(No.ZR2019PH051) （No.ZR2019PH051）
